Lindmik Pharmaceutical (Suzhou) Co., Ltd.
PrivateLast Round
Early Funding
Jun 7, 2024
Total Funding Raised
$14M
Company Overview
Lindmik Pharmaceutical (Suzhou) Co., Ltd. is a pharmaceutical company that focuses on the research and development, production, and sales of innovative pharmaceutical preparations, particularly in the field of transdermal drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lindmik Pharmaceutical (Suzhou) Co., Ltd. Comparables
Compare Lindmik Pharmaceutical (Suzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sino Biopharmaceutical | 83% | |
| Hunan Jiudian Pharmaceutical Co Ltd | 71% | |
| Hisamitsu Pharmaceutical Co., Inc. | 68% |
Lindmik Pharmaceutical (Suzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 7, 2024 | ||||
| Pre-A Round | Sep 29, 2021 | ||||
| Angel | Dec 1, 2020 |
Lindmik Pharmaceutical (Suzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fuhui Venture Capital | Early Funding |
| CCIC Capital | Early Funding |
| Suzhou Wuzhong Biological Medicine Industry Investment Company | Angel, Pre-A Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 7, 2024
$14M raised, led by CCIC Capital.
- Sep 29, 2021
$3.1M round led by Suzhou Wuzhong Biological Medicine Industry Investment Company
Lindmik Pharmaceutical (Suzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lindmik Pharmaceutical (Suzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Lindmik Pharmaceutical (Suzhou) Co., Ltd. a public or private company?
Lindmik Pharmaceutical (Suzhou) Co., Ltd. is a private company.
What is the current stock price of Lindmik Pharmaceutical (Suzhou) Co., Ltd.?
Lindmik Pharmaceutical (Suzhou) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Lindmik Pharmaceutical (Suzhou) Co., Ltd. worth (valuation)?
Valuation information for Lindmik Pharmaceutical (Suzhou) Co., Ltd. is not publicly available.
Can I buy Lindmik Pharmaceutical (Suzhou) Co., Ltd. stock?
Lindmik Pharmaceutical (Suzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lindmik Pharmaceutical (Suzhou) Co., Ltd.'s last funding round?
Lindmik Pharmaceutical (Suzhou) Co., Ltd.'s most recent funding round was Early Funding on June 7, 2024.
Who are the main investors in Lindmik Pharmaceutical (Suzhou) Co., Ltd.?
Key investors in Lindmik Pharmaceutical (Suzhou) Co., Ltd. include CCIC Capital.
Will Lindmik Pharmaceutical (Suzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Lindmik Pharmaceutical (Suzhou) Co., Ltd..
How can I track Lindmik Pharmaceutical (Suzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lindmik Pharmaceutical (Suzhou) Co., Ltd.'s secondary market activity and sign up for updates.